| Central role of high density lipoprotein in plasma free cholesterol metabolism. | |
| | |
MedLine Citation:
|
PMID: 6953075 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This study was designed to provide direct information on the in vivo metabolism in man of free (unesterified) cholesterol in the major lipoprotein classes. Five human subjects were administered one or two (simultaneous) of the following; [2-(14)C] mevalonic acid, high density lipoprotein (HDL)-free [(14)C] cholesterol, low density lipoprotein (LDL)-free [(14)C] cholesterol, and very low density lipoprotein (VLDL)-free [(3)H]cholesterol. Blood was then obtained at frequent intervals for at least 9 h, and the alpha(HDL) and beta(LDL + VLDL) lipoproteins were quickly separated by heparin-manganese precipitation to prevent ex vivo exchange of free cholesterol. After the administration of [(14)C]mevalonic acid the specific activity (disintegrations per minute/micromole) of free cholesterol in the alpha- and beta-lipoproteins increased for 3 h. During this period the alpha-free cholesterol specific activity was higher than the beta specific activity. After administration of VLDL and LDL labeled with free cholesterol, the alpha-free cholesterol specific activity reached a peak value within 20 min, at which time it was considerably lower than the beta-free cholesterol specific activity. When HDL labeled with free cholesterol was administered, a precursor product relationship was observed between the alpha-free cholesterol (precursor) and beta-free cholesterol (product) specific activities.A multicompartmental model was developed that contained the simplest structure necessary to fit all of the data obtained. The kinetic analysis revealed the presence of extensive exchange (20-85 mumol/min) of free cholesterol between HDL and a tissue pool(s) enriched with newly synthesized free cholesterol. It was found that virtually all (>95%) of the free cholesterol in the beta-lipoproteins (LDL+VLDL) cycles directly through HDL. The free cholesterol in LDL appears to behave in the same fashion as the free cholesterol in VLDL. The results show that there are marked differences in the kinetic behavior of the free cholesterol fractions of alpha- and beta-lipoproteins. There is extensive recycling of free cholesterol between HDL and tissue pools, and between HDL and the beta-lipoproteins; this recycling has been quantitated. The findings support the view that in vivo, the free cholesterol in HDL plays a central role in exchange reactions and in the vascular-tissue cholesterol transport system. |
| | |
Authors:
|
C C Schwartz; Z R Vlahcevic; M Berman; J G Meadows; R M Nisman; L Swell |
Related Documents
:
|
9526815 - Use of niacin, statins, and resins in patients with combined hyperlipidemia. 10423715 - Changes in normal lipid profile of menopausal women with combined hormone replacement t... 1517695 - Lipoproteins and apolipoproteins in human pleural effusions. 10197085 - Hdl-cholesterol reductions associated with adult growth hormone replacement. 12752825 - Estimation of the proportion of body fat in mice from the proportion of body water. 1368425 - Colorimetric determination of free and total cholesterol by flow injection analysis wit... |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The Journal of clinical investigation Volume: 70 ISSN: 0021-9738 ISO Abbreviation: J. Clin. Invest. Publication Date: 1982 Jul |
Date Detail:
|
Created Date: 1982-08-14 Completed Date: 1982-08-14 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 7802877 Medline TA: J Clin Invest Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 105-16 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Biliary Fistula / metabolism Biological Transport Cholesterol / administration & dosage, biosynthesis, blood, metabolism* Cholesterol, LDL Cholesterol, VLDL Female Humans Lipoproteins, HDL / metabolism* Lipoproteins, LDL / administration & dosage, metabolism Lipoproteins, VLDL / administration & dosage, metabolism Male Mevalonic Acid / administration & dosage, metabolism Middle Aged Time Factors |
| Grant Support | |
ID/Acronym/Agency:
|
AM 14668/AM/NIADDK NIH HHS; AM 23028/AM/NIADDK NIH HHS; AM 25920/AM/NIADDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Cholesterol, LDL; 0/Cholesterol, VLDL; 0/Lipoproteins, HDL; 0/Lipoproteins, LDL; 0/Lipoproteins, VLDL; 150-97-0/Mevalonic Acid; 57-88-5/Cholesterol |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Regional mapping of the gene coding for enolase-2 on human chromosome 12.
Next Document: Formocresol pulpotomy in primary molars: a long-term radiographic evaluation.